# Studying Amphetamine Withdrawal in Humans

> **NCT01215929** · PHASE2 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 35 (actual)

## Conditions studied

- Methamphetamine Dependence

## Interventions

- **DRUG:** Dextroamphetamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01215929
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2013-04
- **Final completion:** 2014-05
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01215929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01215929, "Studying Amphetamine Withdrawal in Humans". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01215929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*